Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VB10.16 in HPV16+ High Grade Cervical Intraepithelial Neoplasia
NCT02529930Phase 2Completed
- Sponsor
- Nykode Therapeutics
- Start
- Aug 2015
- Primary completion
- Jan 2019
- Modality
- Prophylactic Vaccines, DNA Vaccines, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of VB10.16 in cervical intraepithelial neoplasia (CIN), sponsored by Nykode Therapeutics. Started Aug 2015; status: completed.
02
Drugs
VB10.16
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT02529930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02529930.